...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Free
Message: Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019

Bear that puts topline 21 calendar days from today. (3 weeks away)

 

Koo

Share
New Message
Please login to post a reply